Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of LacdiNAc-glycosylated Prostate-specific Antigen Density for Predicting Pathological Findings of Magnetic Resonance Imaging-transrectal Ultrasound Fusion Image-guided Prostate Biopsy for the Patients With Highest Prostate Imaging Reporting and Data System Category ≥3.
Shoji S, Kaya T, Tanaka Y, Uemura K, Kusaka T, Takahashi K, Yuzuriha S, Kano T, Hanada I, Umemoto T, Ogawa T, Nakano M, Kawakami M, Nitta M, Hasegawa M, Hashida K, Hasebe T, Kaneko T, Okada J, Asai S, Miyajima A. Shoji S, et al. Among authors: okada j. J Urol. 2023 Jan;209(1):187-197. doi: 10.1097/JU.0000000000002958. Epub 2022 Sep 6. J Urol. 2023. PMID: 36067387
Reply by Authors.
Shoji S, Kaya T, Tanaka Y, Uemura K, Kusaka T, Takahashi K, Yuzuriha S, Kano T, Hanada I, Umemoto T, Ogawa T, Nakano M, Kawakami M, Nitta M, Hasegawa M, Hashida K, Hasebe T, Kaneko T, Okada J, Asai S, Miyajima A. Shoji S, et al. Among authors: okada j. J Urol. 2023 Jan;209(1):197. doi: 10.1097/JU.0000000000002958.02. Epub 2022 Sep 28. J Urol. 2023. PMID: 36169486 No abstract available.
Combination of a Topical Anti-Inflammatory Drug and a Moisturizer, Both with a Lamellar Structure Containing Synthetic Pseudo-Ceramides, for the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis.
Okoshi K, Ito S, Matsuoka M, Kinugasa Y, Shimizu E, Tanaka K, Okada J, Nishizaka T, Nagasawa A, Seki T, Iijima M, Abe M, Nemoto O. Okoshi K, et al. Among authors: okada j. Clin Cosmet Investig Dermatol. 2024 Jul 3;17:1569-1578. doi: 10.2147/CCID.S467934. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38974707 Free PMC article.
550 results